Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-02-000973
Filing Date
2002-05-23
Accepted
2002-05-23 16:21:42
Documents
1
Group Members
ORBIMED ADVISORS INC.ORBIMED ADVISORS LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G (LLC) sc13g_052202.txt SC 13G 13714
  Complete submission text file 0000947871-02-000973.txt   15738
Mailing Address 401 QUEEN ANNE AVE NORTH SEATTLE WA 98109
Business Address 4350 EXECUTIVE DRIVE,SUITE 325 SAN DIEGO CA 92121 2062989400
CYPRESS BIOSCIENCE INC (Subject) CIK: 0000716054 (see all company filings)

EIN.: 222389839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-35589 | Film No.: 02661178
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 41 MADISON AVE 40TH FL NEW YORK NY 10010 2126845700
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE